暗盤前瞻丨易和國際控股、宏力醫療管理:均未回撥,在新股熱捧氣氛下是否會被炒作?
uSMART友信智投7月10日消息,今日有2隻新股公佈中簽結果,並將於16:15進行暗盤交易。
兩隻新股都沒有回撥,參照今日虎視傳媒以及近期小票風格,可能會有炒作。
易和國際控股(08659)
易和國際從事設計、開發、生產及銷售一次性塑膠速食盒,是一隻創業板新股。
公開發售認購11.3倍,申請人數只有8262,中簽人數只有2530,1手中簽率13.02%,申購9手穩中1手。公開最多可中18手,中簽市值3.6萬。
國配認購倍數1.23倍,中簽人數157,沒有綠鞋。
保薦人是中毅資本,近兩年保薦了兩隻新股,主機板和創業板各一隻,首日都呈“妖股”式的大升走勢。
宏力醫療管理(09906)
宏力醫療管理集團旗下經營著一家醫院——河南宏力醫院,今年1月被評定為三級醫院。
公開發售認購14.99倍,這個數字非常有意思,剛好不觸及15倍回撥的“紅線”,導致中簽率較低,1手中簽率僅10%,申購45手穩中1手,甲尾最多中10手,乙組只有5人申購,中簽率在40%以上,最多中1522手。
國配認購1.4倍,120人中簽,基石投資者長恒市投資集團認購股數占19.43%。
有綠鞋,但值得注意的是國配中超額分配股數只有440.8萬股,占初始發售股份的2.9%,也就是說若破發,綠鞋對股價的托底作用可能不太大。穩定價格結束期為7月30日,穩價人是交銀國際。
此外,2019年6月公司曾引入一位IPO前投資者,每股成本比發行價2.1港元溢價30%以上,有12個月鎖定期。
暗盤預報
uSMART友信證券暗盤交易時間:7月10日 16:15~18:30
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.